Publications
Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease." Communications Biology 4, no. 1 (2021).
"Biomaterializing the promise of cardiac tissue engineering." Biotechnol Adv 42 (2020).
"Can we mimic skeletal muscles for novel drug discovery?" Expert Opinion on Drug Discovery 15, no. 6 (2020): 643-645.
"Gene Expression Differences In Three-dimensional Myobundles Compared To Two-dimensional Myocultures." In Medicine and Science in Sports and Exercise, 781-782. Vol. 52. 2020.
"Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle." Tissue Engineering and Regenerative Medicine 17, no. 6 (2020): 801-813.
" "Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure." Biomaterials 236 (2020).
"Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers." Toxicological Sciences 176, no. 1 (2020): 124-136.
"Altering integrin engagement regulates membrane localization of Kir2.1 channels." Journal of Cell Science 132, no. 17 (2019).
"Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure." Circulation Research 124, no. 1 (2019): 161-169.
"Electrical stimulation increases hypertrophy and metabolic flux in tissue-engineered human skeletal muscle." Biomaterials 198 (2019): 259-269.
"Engineered skeletal muscles for disease modeling and drug discovery." Biomaterials 221 (2019).
"Ion channel engineering for modulation and de novo generation of electrical excitability." Current Opinion in Biotechnology 58 (2019): 100-107.
"The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice." Jci Insight 4, no. 22 (2019).
"Correction of biochemical abnormalities and gene expression associated with improved muscle function in a phase I/II clinical trial of clenbuterol in Pompe disease patients stably treated with ERT." In Molecular Genetics and Metabolism, S79-S80. Vol. 123. 2018.
"Effects of simulated muscle exercise on chondrocyte gene expression in a 3D-alginate bead model system." In Osteoarthritis and Cartilage, S139-S140. Vol. 26. 2018.
"Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation." Biomaterials 159 (2018): 48-58.
"Engineering human pluripotent stem cells into a functional skeletal muscle tissue." Nature Communications 9, no. 1 (2018).
"Generation and customization of biosynthetic excitable tissues for electrophysiological studies and cell-based therapies." Nature Protocols 13 (2018).
"In Vitro Tissue‐Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease." Advanced Healthcare Materials 1701498 (2018).
"Incorporation of macrophages into engineered skeletal muscle enables enhanced muscle regeneration." Nature Biomedical Engineering 2, no. 12 (2018): 942-954.
"Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function." Acta Biomaterialia 78 (2018): 98-110.
"Microheterogeneity-induced conduction slowing and wavefront collisions govern macroscopic conduction behavior: A computational and experimental study." Plos Computational Biology 14, no. 7 (2018).
"Selective Gq Activation in Cardiac Fibroblasts Decreases Isometric Force Generation in 3D Engineered Cardiac Tissues." In Circulation. Vol. 138. 2018.
"3D Tissue-engineered Model of Pressure-overload Induced Cardiac Fibrosis." In Tissue Engineering. Part A, S64. Vol. 23. 2017.
"